OP-005 Assessment of Warfarin TTR (Time in Therapeutic Range ) Results in a tertiary Reference Center

OP-005 Assessment of Warfarin TTR (Time in Therapeutic Range ) Results in a tertiary Reference Center

Anticoagulant drugs (warfarin, UFH and LMWH, and direct thrombin and factor Xa inhibitors) routinely used for the prevention of thromboembolism in patients with nonvalvular AF, mechanical heart valves, deep venous thrombosis, intracavitary thrombus.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2015-03, Vol.115, p.S2-S3
Hauptverfasser: Tekkesin, Ahmet Ilker, Cakilli, Yasin, Turkkan, Ceyhan, Demir, Koray, Borklu, Edibe Betul, Yildirimturk, Ozlem, Cinier, Goksel, Alper, Ahmet Taha
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Cardiovascular
Drug therapy
Thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S3
container_issue
container_start_page S2
container_title The American journal of cardiology
container_volume 115
creator Tekkesin, Ahmet Ilker
Cakilli, Yasin
Turkkan, Ceyhan
Demir, Koray
Borklu, Edibe Betul
Yildirimturk, Ozlem
Cinier, Goksel
Alper, Ahmet Taha
description Anticoagulant drugs (warfarin, UFH and LMWH, and direct thrombin and factor Xa inhibitors) routinely used for the prevention of thromboembolism in patients with nonvalvular AF, mechanical heart valves, deep venous thrombosis, intracavitary thrombus.
doi_str_mv 10.1016/j.amjcard.2015.01.051
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1662460647</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914915001460</els_id><sourcerecordid>3621793141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1857-9560812028612a20abc2ee1bde5d2488b7f893b15147a500aa45f53d2d89ede73</originalsourceid><addsrcrecordid>eNqFUdtKw0AQXUTBevkEYcEXfUic2WRzeVGkeIOCUis-LtvNRDe2Sd1Nhf69GyoIvvg0zO3MOWcYO0GIETC7aGK9bIx2VSwAZQwYg8QdNsIiLyMsMdllIwAQUYlpuc8OvG9CiiizEaPHpwhA8mvvyfsltT3vav6qXa2dbflsNuVnM7skPiTv5PSK1r01fKrbN-LnfEp-vej90Na8J9db7TahWpOj1hAfB0RyR2yv1gtPxz_xkL3c3szG99Hk8e5hfD2JDBYyj0qZQYECRJGh0AL03AginFckK5EWxTyvizKZo8Q01xJA61TWMqlEVZRUUZ4cstMt7sp1n2vyvWq6tWvDSYVZJtIMsnSYktsp4zrvHdVq5ewy8FYIanBUNerHUTU4qgBVcDTsXW33KEj4suSUN3ZQWVlHpldVZ_9FuPyDYBa2tUYvPmhD_pes8kKBeh6-NjwNg1gM7JNvp9eTvQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1662460647</pqid></control><display><type>article</type><title>OP-005 Assessment of Warfarin TTR (Time in Therapeutic Range ) Results in a tertiary Reference Center</title><source>Elsevier ScienceDirect Journals</source><creator>Tekkesin, Ahmet Ilker ; Cakilli, Yasin ; Turkkan, Ceyhan ; Demir, Koray ; Borklu, Edibe Betul ; Yildirimturk, Ozlem ; Cinier, Goksel ; Alper, Ahmet Taha</creator><creatorcontrib>Tekkesin, Ahmet Ilker ; Cakilli, Yasin ; Turkkan, Ceyhan ; Demir, Koray ; Borklu, Edibe Betul ; Yildirimturk, Ozlem ; Cinier, Goksel ; Alper, Ahmet Taha</creatorcontrib><description>Anticoagulant drugs (warfarin, UFH and LMWH, and direct thrombin and factor Xa inhibitors) routinely used for the prevention of thromboembolism in patients with nonvalvular AF, mechanical heart valves, deep venous thrombosis, intracavitary thrombus.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2015.01.051</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Anticoagulants ; Cardiovascular ; Drug therapy ; Thrombosis</subject><ispartof>The American journal of cardiology, 2015-03, Vol.115, p.S2-S3</ispartof><rights>2015</rights><rights>Copyright Elsevier Limited Mar 16, 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002914915001460$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Tekkesin, Ahmet Ilker</creatorcontrib><creatorcontrib>Cakilli, Yasin</creatorcontrib><creatorcontrib>Turkkan, Ceyhan</creatorcontrib><creatorcontrib>Demir, Koray</creatorcontrib><creatorcontrib>Borklu, Edibe Betul</creatorcontrib><creatorcontrib>Yildirimturk, Ozlem</creatorcontrib><creatorcontrib>Cinier, Goksel</creatorcontrib><creatorcontrib>Alper, Ahmet Taha</creatorcontrib><title>OP-005 Assessment of Warfarin TTR (Time in Therapeutic Range ) Results in a tertiary Reference Center</title><title>The American journal of cardiology</title><description>Anticoagulant drugs (warfarin, UFH and LMWH, and direct thrombin and factor Xa inhibitors) routinely used for the prevention of thromboembolism in patients with nonvalvular AF, mechanical heart valves, deep venous thrombosis, intracavitary thrombus.</description><subject>Anticoagulants</subject><subject>Cardiovascular</subject><subject>Drug therapy</subject><subject>Thrombosis</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFUdtKw0AQXUTBevkEYcEXfUic2WRzeVGkeIOCUis-LtvNRDe2Sd1Nhf69GyoIvvg0zO3MOWcYO0GIETC7aGK9bIx2VSwAZQwYg8QdNsIiLyMsMdllIwAQUYlpuc8OvG9CiiizEaPHpwhA8mvvyfsltT3vav6qXa2dbflsNuVnM7skPiTv5PSK1r01fKrbN-LnfEp-vej90Na8J9db7TahWpOj1hAfB0RyR2yv1gtPxz_xkL3c3szG99Hk8e5hfD2JDBYyj0qZQYECRJGh0AL03AginFckK5EWxTyvizKZo8Q01xJA61TWMqlEVZRUUZ4cstMt7sp1n2vyvWq6tWvDSYVZJtIMsnSYktsp4zrvHdVq5ewy8FYIanBUNerHUTU4qgBVcDTsXW33KEj4suSUN3ZQWVlHpldVZ_9FuPyDYBa2tUYvPmhD_pes8kKBeh6-NjwNg1gM7JNvp9eTvQ</recordid><startdate>20150316</startdate><enddate>20150316</enddate><creator>Tekkesin, Ahmet Ilker</creator><creator>Cakilli, Yasin</creator><creator>Turkkan, Ceyhan</creator><creator>Demir, Koray</creator><creator>Borklu, Edibe Betul</creator><creator>Yildirimturk, Ozlem</creator><creator>Cinier, Goksel</creator><creator>Alper, Ahmet Taha</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20150316</creationdate><title>OP-005 Assessment of Warfarin TTR (Time in Therapeutic Range ) Results in a tertiary Reference Center</title><author>Tekkesin, Ahmet Ilker ; Cakilli, Yasin ; Turkkan, Ceyhan ; Demir, Koray ; Borklu, Edibe Betul ; Yildirimturk, Ozlem ; Cinier, Goksel ; Alper, Ahmet Taha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1857-9560812028612a20abc2ee1bde5d2488b7f893b15147a500aa45f53d2d89ede73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anticoagulants</topic><topic>Cardiovascular</topic><topic>Drug therapy</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tekkesin, Ahmet Ilker</creatorcontrib><creatorcontrib>Cakilli, Yasin</creatorcontrib><creatorcontrib>Turkkan, Ceyhan</creatorcontrib><creatorcontrib>Demir, Koray</creatorcontrib><creatorcontrib>Borklu, Edibe Betul</creatorcontrib><creatorcontrib>Yildirimturk, Ozlem</creatorcontrib><creatorcontrib>Cinier, Goksel</creatorcontrib><creatorcontrib>Alper, Ahmet Taha</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tekkesin, Ahmet Ilker</au><au>Cakilli, Yasin</au><au>Turkkan, Ceyhan</au><au>Demir, Koray</au><au>Borklu, Edibe Betul</au><au>Yildirimturk, Ozlem</au><au>Cinier, Goksel</au><au>Alper, Ahmet Taha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>OP-005 Assessment of Warfarin TTR (Time in Therapeutic Range ) Results in a tertiary Reference Center</atitle><jtitle>The American journal of cardiology</jtitle><date>2015-03-16</date><risdate>2015</risdate><volume>115</volume><spage>S2</spage><epage>S3</epage><pages>S2-S3</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Anticoagulant drugs (warfarin, UFH and LMWH, and direct thrombin and factor Xa inhibitors) routinely used for the prevention of thromboembolism in patients with nonvalvular AF, mechanical heart valves, deep venous thrombosis, intracavitary thrombus.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.amjcard.2015.01.051</doi></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2015-03, Vol.115, p.S2-S3
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_journals_1662460647
source Elsevier ScienceDirect Journals
subjects Anticoagulants
Cardiovascular
Drug therapy
Thrombosis
title OP-005 Assessment of Warfarin TTR (Time in Therapeutic Range ) Results in a tertiary Reference Center
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T16%3A41%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=OP-005%20Assessment%20of%20Warfarin%20TTR%20(Time%20in%20Therapeutic%20Range%20)%20Results%20in%20a%20tertiary%20Reference%20Center&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Tekkesin,%20Ahmet%20Ilker&rft.date=2015-03-16&rft.volume=115&rft.spage=S2&rft.epage=S3&rft.pages=S2-S3&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2015.01.051&rft_dat=%3Cproquest_cross%3E3621793141%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1662460647&rft_id=info:pmid/&rft_els_id=S0002914915001460&rfr_iscdi=true